Investigational Injectable Drug Demonstrates Efficacy in Localized Fat Reduction
Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.
Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.
A new fat-based injectable is reshaping non-surgical body contouring. Plastic Surgery Practice examines the science and clinical adoption of alloClae with Tiger Aesthetics President Caroline Van Hove and Dr David Shafer.